Skip to main content
Clinical Trials/NL-OMON41295
NL-OMON41295
Recruiting
Not Applicable

The effect of ARTISS on latissimus dorsi donor site seroma formation after breast reconstruction: a randomised controlled trial. - The use of ARTISS to prevent seroma: a randomized controlled trial

Isala Klinieken0 sites121 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Isala Klinieken
Enrollment
121

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • All female patients older than 18 years, who will undergo a breast reconstruction with a LD flap will be included. All participating patients have to sign a written consent, before they can be included in our study.

Exclusion Criteria

  • Patients who are pregnant, have a pre\-operative on\-going infection, history of systemic anti\-coagulant use, known hypersensitivity to ARTISS or postoperative haemorrhage will be excluded.

Investigators

Sponsor
Isala Klinieken

Similar Trials